Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey †
Normalization of acceleromyographic train-of-four ratio by baseline value for detecting residual neuromuscular block
Neuromuscular Blocking Agents
Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20) ,
Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium
Neuromuscular Block
Neuromuscular Block.
Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery
Neuromuscular Blocking Drugs
Reversal of rocuronium-induced (1.2 mg kg −1 ) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg −1 ) †
